Bupropion Hydrochloride

Product NDC
76282-481
11-digit product format
762820481
Labeler code
76282
Product ID
76282-481_9fff6e28-19e0-43ad-85c8-57d111b990bb
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
bupropion hydrochloride
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Labeler
Exelan Pharmaceuticals Inc.
Application
ANDA206556
Marketing category
ANDA
Marketing start
2017-06-12
Substance
BUPROPION HYDROCHLORIDE
Active strength
300 mg/1
Pharmacologic classes
Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Bupropion Hydrochloride
Brand name suffix
(XL)
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
BUPROPION HYDROCHLORIDE300 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
UniiZG7E5POY8O
Rxcui993541, 993557

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
4eceb285-f3c7-4092-a21a-4c9f3169f20cProduct name520260220
fb7ab793-2c12-4079-b100-a64f73bef25aProduct name420240712
548ba7fd-fd0c-4a21-b2b0-d01bf93143b8Product name320240209
b0cbf770-6cc3-4aa4-9158-755110c2b9f7Product name220230717
dc7c5daa-021f-40dd-b00d-63982cb2067aProduct name120230426
43a1ed49-eae2-4840-8075-cb4b33478540Product name120230425
08ffbcbf-26df-b99c-1dab-64fc4cfae89fProduct name520200925
b8ee525f-67fb-39fb-91da-7e47ac54581dProduct name520200611
816b97af-edc5-4060-aff1-b814bdbcad50Product name120190415
98e65af1-f5d0-75d5-c930-f8a4ce4c3284Product name920190211
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
419aab54-5d5a-4146-9453-026d4a9991beProduct name220170525
08ffbcbf-26df-b99c-1dab-64fc4cfae89fProduct name220160823
e4d463bc-c674-43cb-be06-82786f310d01Product name120150326
89dac932-b90a-4410-9ab1-84c53e57de25Product name120150316
0916dcfb-331f-89b1-8eac-6f7dc76d82daProduct name120140508
d7fc3d53-5a6c-de82-2808-1780f175f17eProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
76282-481-05Bupropion Hydrochloride(XL)500 in 1 BOTTLETABLET, EXTENDED RELEASE5009
76282-481-30Bupropion Hydrochloride(XL)30 in 1 BOTTLETABLET, EXTENDED RELEASE309
76282-481-90Bupropion Hydrochloride(XL)90 in 1 BOTTLETABLET, EXTENDED RELEASE909

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
76282-481BUPROPION HYDROCHLORIDE (XL) (BUPROPION HYDROCHLORIDE) TABLET, EXTENDED RELEASE [EXELAN PHARMACEUTICALS INC.]9Current NDC, Legacy NDC, 3 package rows20231012_8a0781c0-e7d5-498e-b7d3-d6bd457f175f.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
993541buPROPion HCl 150 MG 24HR Extended Release Oral TabletPSN8a0781c0-e7d5-498e-b7d3-d6bd457f175f9
993557buPROPion HCl 300 MG 24HR Extended Release Oral TabletPSN8a0781c0-e7d5-498e-b7d3-d6bd457f175f9
99354124 HR bupropion hydrochloride 150 MG Extended Release Oral TabletSCD8a0781c0-e7d5-498e-b7d3-d6bd457f175f9
99355724 HR bupropion hydrochloride 300 MG Extended Release Oral TabletSCD8a0781c0-e7d5-498e-b7d3-d6bd457f175f9
993541bupropion HCl XL 150 MG 24 HR Extended Release Oral TabletSY8a0781c0-e7d5-498e-b7d3-d6bd457f175f9
993557bupropion HCl XL 300 MG 24 HR Extended Release Oral TabletSY8a0781c0-e7d5-498e-b7d3-d6bd457f175f9

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
76282-481-0576282048105500 TABLET, EXTENDED RELEASE in 1 BOTTLE (76282-481-05) 2022-02-100000-00-00NoNoCurrent
76282-481-307628204813030 TABLET, EXTENDED RELEASE in 1 BOTTLE (76282-481-30) 2017-06-120000-00-00NoNoCurrent
76282-481-907628204819090 TABLET, EXTENDED RELEASE in 1 BOTTLE (76282-481-90) 2022-02-100000-00-00NoNoCurrent